(Q33946117)

English

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

Garrett M Brodeur

5

object named as

Brodeur GM

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Robert C Seeger

4

object named as

Seeger RC

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Katherine K Matthay

9

object named as

Matthay KK

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Rudnick E

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Khakoo Y

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Antunes NL

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Shimada H

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gerbing RB

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Stram DO

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pediatric Blood & Cancer

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

612-622

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

The neurobiology of the opsoclonus-myoclonus syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Opsomyoclonus and neuroblastoma. Response to ACTH.

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Antineuronal Antibodies in Patients With Neuroblastoma and Paraneoplastic Opsoclonus-Myoclonus

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer?A quantitative western blot analysis

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Paraneoplastic anti-Hu serum: studies on human tumor cell lines

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Opsoclonus-ataxia due to childhood neural crest tumors: a chronic neurologic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Myoclonic encephalopathy of infancy: a 10 year review

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Outcome of children with opsoclonus-myoclonus regardless of etiology.

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1138

21 January 2018

Identifiers

10.1002/MPO.1138

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33946117&oldid=2186417960"